Earnings
STAAR Surgical Couldn't Fill All China Lens Orders, So Price Alone Drove Its Growth There
The lens maker's China sales rose 31% excluding last year's deferred sales, and management would not give 2027 guidance.
STAAR Surgical (STAA) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Earnings
The lens maker's China sales rose 31% excluding last year's deferred sales, and management would not give 2027 guidance.
Earnings
The lens maker earned $5.6 million in the third quarter, and its CFO said gross margin pressure should ease from the fourth quarter.
SEC Filings
Receivables owed by China jumped to $86.5 million even as STAAR posted a profit and a $50.0 million buyback sat untouched.
SEC Filings
An amended 8-K says the dollar values were right but the original filing listed the wrong mix of stock units and options in the returning executive's package.